Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1986 Apr;83(8):2628-31.
doi: 10.1073/pnas.83.8.2628.

Site-directed mutagenesis of an invariant amino acid residue at the variable-diversity segments junction of an antibody

Site-directed mutagenesis of an invariant amino acid residue at the variable-diversity segments junction of an antibody

J Sharon et al. Proc Natl Acad Sci U S A. 1986 Apr.

Abstract

Structural analysis of 21 murine A/J antibodies specific for the hapten p-azobenzenearsonate (Ars), and bearing the major cross reactive idiotype (IdCRI), has revealed an invariant amino acid residue, serine, encoded by the variable-diversity gene segments junction of the heavy chain. To test whether this serine residue is essential for Ars binding, we changed it either to alanine or to threonine by oligonucleotide-directed mutagenesis of a heavy chain gene. Genes containing the mutations were separately introduced into mouse hybridoma cells producing the homologous light chain, and the resulting proteins were tested for antigen binding and idiotypic expression. Whereas the serine to threonine mutant retains full antigen binding activity, the serine to alanine mutant does not bind either to Ars-bovine serum albumin-Sepharose or to the Ars-tyrosine hapten. Both mutants show the same reactivity as wild type towards a series of anti-idiotypic antibodies. These results suggest that a hydroxyl group at the variable-diversity gene segments junction of A/J anti-Ars antibodies is essential for antigen binding.

PubMed Disclaimer

References

    1. Nature. 1970 Aug 15;227(5259):680-5 - PubMed
    1. Nature. 1985 Jun 6-12;315(6019):506-8 - PubMed
    1. J Exp Med. 1973 Dec 1;138(6):1496-505 - PubMed
    1. Eur J Immunol. 1974 Jan;4(1):29-33 - PubMed
    1. J Immunol. 1978 Dec;121(6):2305-10 - PubMed

Publication types

LinkOut - more resources